Table 1:
Transcatheter | Operative | p-value | |
---|---|---|---|
n=295 at 34 centers | n=5919 at 44 centers | ||
Age at PDA closure (days) | 74 (IQR 44–105) | 23 (IQR 14–34) | <0.001 |
Female sex | 51% (n=150) | 46% (n=2,750) | 0.14 |
Race | 0.05 | ||
White | 43% (n=126) | 50% (n=2,966) | |
Black | 33% (n=98) | 27% (n=1,587) | |
Other or mixed race | 4% (n=12) | 5% (n=279) | |
Missing | 20% (n=59) | 18% (n=1,087) | |
Payer | 0.04 | ||
Private insurance | 39% (n=114) | 34% (n=1,985) | |
Public insurance | 57% (n=167) | 57% (n=3,384) | |
Non-public government | 2% (n=6) | 4% (n=259) | |
Other | 2% (n=7) | 5% (n=274) | |
Missing | <1% (n=1) | <1% (n=17) | |
Gestational age (weeks) | 26 (IQR 25–30) | 25 (IQR 24–26) | <0.001 |
Gestational age | <0.001 | ||
23–24 weeks | 17% (n=50) | 31% (n=1,829) | |
25–27 weeks | 30% (n=87) | 39% (n=2,310) | |
28–33 weeks | 16% (n=48) | 10% (n=581) | |
34–36 weeks | 4% (n=12) | 1% (n=66) | |
≥37 weeks | 8% (n=23) | 1% (n=87) | |
Missing | 25% (n=75) | 18% (n=1,046) | |
Adjusted gestational age (weeks) | 36 (30–38) | 29 (IQR 27–31) | <0.001 |
Adjusted gestational age | <0.001 | ||
23–24 | <1% (n=1) | 4% (n=220) | |
25–27 | 4% (n=13) | 30% (n=1,782) | |
28–33 | 15% (n=43) | 39% (n=2,330) | |
34–36 | 10% (n=29) | 4% (n=251) | |
≥37 | 45% (n=134) | 5% (n=290) | |
Missing | 25% (n=75) | 18% (n=1,046) | |
Known genetic syndrome | 4% (n=11) | 2% (n=101) | 0.01 |
History of gastrointestinal condition | 38% (n=112) | 19% (n=1,151) | <0.001 |
History of hematologic condition | 3% (n=8) | 3% (n=188) | 0.66 |
History of neurologic condition | 18% (n=53) | 14% (n=851) | 0.09 |
History of respiratory condition | 29% (n=87) | 16% (n=951) | <0.001 |
Other complex chronic condition | 84% (n=248) | 89% (n=5,286) | 0.48 |